Literature DB >> 21389643

Mitochondrial DNA alterations in colorectal cancer cell lines.

Naoto Chihara1, Taku Amo, Akira Tokunaga, Ryo Yuzuriha, Alexander M Wolf, Sadamitsu Asoh, Hideyuki Suzuki, Eiji Uchida, Shigeo Ohta.   

Abstract

Somatic mutations of mitochondrial DNA (mtDNA) have been reported in different types of cancers and are suggested to play roles in metastasis, cancer development and response to anticancer agents. To predict potential roles of mtDNA alterations in colorectal cancer, we determined the entire mtDNA sequence of eleven human-derived colorectal cancer cell lines and compared with the revised Cambridge Reference Sequence to identify nucleotide alterations. Four homoplasmic and six heteroplasmic alterations were found to be novel. Among them, homoplasmic G6709A (MT-CO1) and G14804A (MT-CYB) alterations cause amino acid changes in the highly conserved residues. Heteroplasmic G1576A (MT-RNR1) and G2975A (MT-RNR2) alterations are expected to make the stem structure of mitochondrial ribosomal RNAs unstable. These nucleotide alterations are candidates that could play important roles in cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389643     DOI: 10.1272/jnms.78.13

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  5 in total

Review 1.  Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?

Authors:  Han Shuwen; Yang Xi; Pan Yuefen
Journal:  Dis Markers       Date:  2017-03-16       Impact factor: 3.434

2.  Cisplatin selects short forms of the mitochondrial DNA OriB variant (16184-16193 poly-cytosine tract), which confer resistance to cisplatin.

Authors:  Taku Amo; Naomi Kamimura; Hiromasa Asano; Sadamitsu Asoh; Shigeo Ohta
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

3.  Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells.

Authors:  Ji Hee Kang; Young Tag Ko
Journal:  Pharmaceutics       Date:  2019-08-20       Impact factor: 6.321

Review 4.  The Interplay of Tumor Stroma and Translational Factors in Endometrial Cancer.

Authors:  Monika Sobočan; Maria Anna Smolle; Christoph Schatz; Johannes Haybaeck
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

5.  Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.

Authors:  Marco Fiorillo; Rebecca Lamb; Herbert B Tanowitz; Luciano Mutti; Marija Krstic-Demonacos; Anna Rita Cappello; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2016-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.